SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015523
Filing Date
2022-08-08
Accepted
2022-08-08 16:10:53
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-20220630.htm   iXBRL 10-Q 2625248
2 EX-10.1 sndx-ex10_1.htm EX-10.1 80287
3 EX-31.1 sndx-ex31_1.htm EX-31.1 16970
4 EX-31.2 sndx-ex31_2.htm EX-31.2 17360
5 EX-32.1 sndx-ex32_1.htm EX-32.1 17597
  Complete submission text file 0000950170-22-015523.txt   9749061

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20220630_pre.xml EX-101.PRE 293295
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sndx-20220630_def.xml EX-101.DEF 181989
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20220630.xsd EX-101.SCH 51856
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20220630_lab.xml EX-101.LAB 391502
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sndx-20220630_cal.xml EX-101.CAL 49127
60 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20220630_htm.xml XML 2180211
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 221144460
SIC: 2834 Pharmaceutical Preparations